陆瑶, 张迁, 程千吉, 刘佳宁, 孙铭谣, 宁金铃, 黄嘉杰, 任似梦, 张文政, 刘雅洁, 邓锡源, 田金徽, 刘杰, 葛龙. 中国患者决策辅助工具开发流程与方法[J]. 协和医学杂志. DOI: 10.12290/xhyxzz.2023-0608
引用本文: 陆瑶, 张迁, 程千吉, 刘佳宁, 孙铭谣, 宁金铃, 黄嘉杰, 任似梦, 张文政, 刘雅洁, 邓锡源, 田金徽, 刘杰, 葛龙. 中国患者决策辅助工具开发流程与方法[J]. 协和医学杂志. DOI: 10.12290/xhyxzz.2023-0608
LU Yao, ZHANG Qian, CHENG Qianji, LIU Jianing, SUN Mingyao, NING Jinling, HUANG Jiajie, REN Simeng, ZHANG Wenzheng, LIU Yajie, DENG Xiyuan, TIAN Jinhui, LIU Jie, GE Long. Method for Developing Patient Decision Aid in China[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2023-0608
Citation: LU Yao, ZHANG Qian, CHENG Qianji, LIU Jianing, SUN Mingyao, NING Jinling, HUANG Jiajie, REN Simeng, ZHANG Wenzheng, LIU Yajie, DENG Xiyuan, TIAN Jinhui, LIU Jie, GE Long. Method for Developing Patient Decision Aid in China[J]. Medical Journal of Peking Union Medical College Hospital. DOI: 10.12290/xhyxzz.2023-0608

中国患者决策辅助工具开发流程与方法

Method for Developing Patient Decision Aid in China

  • 摘要: 目的 在医患共决策的驱动下,系统性研制中国患者决策辅助工具开发流程与方法,以期为相关研究人员开发患者决策辅助工具提供方法学指导。方法 文献回顾国际上患者决策辅助工具开发的方法学资料,梳理不同组织患者决策辅助工具开发流程与方法的异同,结合核心工作组专题讨论,形成开发方法初稿,随后邀请多学科领域专家进行德尔菲共识,根据共识意见对初稿内容进行修订和完善,再次征求专家意见后,最终定稿。结果 共纳入13个框架或方法,形成包含3个阶段、13个步骤和48条要点的开发方法初稿,邀请了19名多学科领域专家进行共识,最终形成包含3个阶段、11个步骤和24条要点的开发方法终稿。结论 该方法为我国决策辅助工具的开发提供了指导,有望填补该领域的方法学空缺。未来将基于具体决策问题对该方法进行多轮试点,以便进一步修订与完善。

     

    Abstract: Objective systematically constructing a guideline to provide a methodological guide for researchers to develop patient decision aids. Methods Through a literature review of international methodological guidance for developing patient decision aids, sorting out the similarities and differences in the processes and methods for developing patient decision aids, and combining with the topic discussion of the working group, drafting the initial guideline. Results A total of 13 guidance was included, and an initial version containing 3 phases, 13 steps, and 48 points. We invited 19 multidisciplinary domain experts for consensus. The final version of the guideline contains 3 phases, 11 steps, and 24 points. Conclusion The guideline will guide the development of patient decision aids in China and is expected to fill the methodological gap in the field. In the future, several rounds of pilot testing of the guideline based on specific decision issues will be conducted, and the guideline will be further revised and improved.

     

/

返回文章
返回